Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up    |  Already a member? Sign In
Pharma IQ

Survey: Improving Solubility 2012

Contributor: Pharma IQ Surveys
Posted: 2/20/2012


Survey: Improving Solubility 2012 - Pharma IQ Surveys

In preparation for the 8th Annual Improving Solubility Summit, taking place in June, we would like to invite you to take part in a short survey. The survey consists of no more than 8 questions and will take less than 3 minutes to complete. Full Article »

Events related to this topic:

Developing Clinical Trials for Oncology Part 2: Outsourcing and Strategic Alliances

Contributor: Denis Mir
Posted: 9/22/2011


Developing Clinical Trials for Oncology Part 2: Outsourcing and Strategic Alliances - Denis Mir

Denis Mir, Senior Manager of Clinical Operations in Oncology at Eisai Global Clinical Development, shares his thoughts on outsourcing and strategic alliances in clinical trials and the key criteria for selecting the right outsouricng partner. Full Video »

Events related to this topic:

REWIND: Reverse Logistics in Clinical Trial Supply

Contributor: Andrea Charles
Posted: 10/28/2011


REWIND: Reverse Logistics in Clinical Trial Supply - Andrea Charles

"Each day we move forward is a day closer to commercial availability. If a trial stops in many cases so does the potential revenue that everyone is looking forward to," said Robert Bronstein, Director - Clinical Supply Operations MacroGenics. In this interview Bronstein discusses the scale of reverse logistics clinical trial supply, MarcoGenics returns process in clinical operations and reducing risk in logistics. Full Podcast »

Events related to this topic:

63% of Pharmaceutical Experts Expect Outsourcing Activity to Increase

Posted: 1/11/2012

63% of Pharmaceutical Experts Expect Outsourcing Activity to Increase

With increasing pressure on pharmaceutical organisations to cut costs and streamline processes, many are deciding to outsource clinical trials. In the current economic climate, outsourcers can provide a key way to continue drug development and trials without incurring the associated costs. Full Whitepaper »

Events related to this topic:
About Clinical

This portal provides executives working within clinical trials, with practical approaches to clinical development in order to enable faster go / no-go decisions, reduce cost and speed time to market.


Advertisement

Events of Interest
Download Brochure

Please complete the information below to complete your download.

Please note: That all fields marked with an asterisk (*) are required.

First Name *
Last Name *
Job Title *
Company Name *
Email Address *
Telephone *
Country *
Where did you hear about us? *

I would like to receive information about sponsorship and exhibition opportunities

Yes, sign me up for the FREE Pharma IQ e-newsletter, including information on FREE Podcasts, Webinars, event discounts and online learning opportunities.

sir, we have a printing unit I want printing orders how to apply here

Posted by:  chikkegowda g | Answer this question

sir, we have a printing unit I want printing orders how to apply here

Posted by:  chikkegowda g | Answer this question

May I know the exact difference between DMF grade and non-DMF grade material?

Posted by:  sumankakimani1 | Answer this question

Hi What is the Job Profile of AREA BUSINESS MANAGER in PHARMA.

Posted by:  digvijay_singh24 | Answer this question

what is QA & QC Division In pharma .

Posted by:  amita25683 | Answer this question

How are GSK making leaps and strides in biopharma?

Posted by:  pharma_eye | Answer this question

Hi What is the Job Profile of AREA BUSINESS MANAGER in PHARMA.

Posted by:  digvijay_singh24 | Answer this question

What is a current topic of discussion in the pharmaceutical industry that could have an impact on pharmaceutical companies?

Posted by:  charlottebooth06@hotmail.co.uk | Answer this question